2min chapter

The Curbsiders Internal Medicine Podcast cover image

#401 Updates in Addiction Medicine - SGIM 2023

The Curbsiders Internal Medicine Podcast

CHAPTER

The FDA Approves the First Naloxone Product for Use Without Prescription

The FDA approved the first naloxone product for use without a prescription, and they did this to help reduce opioid overdose deaths. The anticipated timeline is that this will probably be available in pharmacies in the late summer of 2023. But the manufacturer gets to determine the timeline for when it's available and how much it's going to cost.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode